• Despite the political “ESG backlash” narrative in the US, disclosure laws in the EU, California, New York, and other states—along with the EU’s Empowering Consumers for the Green Transition directive—are accelerating climate target setting and reporting in pharma

• Get an industry trends update with a sneak preview of our 2025 Carbon Impact of Biotech and Pharma report

• Learn how certification and verification can minimize greenwashing risks while ensuring compliance with evolving global regulations

• Discover how to translate corporate climate pledges into measurable lab-level impact, building a lasting culture of sustainability within your organization